Expanding use of medications for opioid use disorder, MOUD, particularly in criminal justice settings (CJS) remains a persistent challenge for many reasons, including stigma, funding for MOUD, availability treatment providers, leadership support, and the historical preference for behavioral therapy-based treatment practices.
The University of Wisconsin’s Center for Health Enhancement and Systems Studies (CHESS) and George Mason University’s Center for Advancing Correctional Excellence! (ACE!) are conducting a randomized controlled trial to determine the optimal combination and dosages for two different coaching strategies to disseminate MOUD in justice-involved populations: the NIATx model for process improvement and Extension for Community Healthcare Outcomes (ECHO) model.
This study is conducted as part of the Justice Community Opioid Innovation Network (JCOIN), a component of the Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM, provides support to study approaches to increase high-quality care for people with opioid misuse and opioid use disorder in justice settings. JCOIN will test strategies to expand effective treatment and care in partnership with local and state justice systems and community-based treatment providers.
This project brings the NIATx model into the JCOIN. The study team will help test combinations of evidence-based practices for implementing medication-assisted treatment for opioid use disorder in criminal justice populations following incarceration.
Read the full article describing the study:
Fostering MOUD use in justice populations: Assessing the comparative effectiveness of two favored implementation studies to increase MOUD use